# Tirzepatide Maintenance Dose: What the Label Says

**By telos rx Editorial Team** · 2026-11-12

**The tirzepatide maintenance dose on the Zepbound label is one of three weekly options, chosen by your prescriber for response and tolerability. Lower [microdosed tirzepatide](https://telosrx.com/pages/microdosed-tirzepatide) for maintenance is off-label and decided by a licensed provider.**

You reached a point you are happy with. Now what? That is the question behind most searches for a tirzepatide maintenance dose.

This guide explains what the FDA label says, what the maintenance research found, and where microdosing fits. It does not give you a dose to follow. Your prescriber sets that.

## What "maintenance dose" means

A maintenance dose is the weekly dose a person stays on after the step-up phase. It is meant to be the long-term dose, not a starting dose.

For branded tirzepatide, the label names specific maintenance options. For compounded tirzepatide, doses are set individually by the prescribing provider. The two are different products.

Zepbound and Mounjaro are FDA-approved branded drugs. Compounded tirzepatide is not FDA-approved and is not the same product, even though it contains the same active ingredient.

## What the Zepbound label actually says

The [original Zepbound prescribing information](https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/217806s000lbl.pdf) on accessdata.fda.gov describes a stepwise start. Doses rise gradually, with at least four weeks on each step.

The label lists 5 mg, 10 mg and 15 mg once weekly as the recommended maintenance dosages. It tells prescribers to consider treatment response and tolerability when choosing among them. It sets 15 mg as the maximum.

Later label updates added other indications, so always check the current version. Most importantly, the label is written for prescribers. It is not a do-it-yourself plan.

## Average tirzepatide maintenance dose: is there one?

No single "average" maintenance dose is published for everyday practice. The label offers a range, and people land in different places.

Some people settle on a lower labelled option because it controls appetite well with fewer side effects. Others need a higher one. Your provider weighs your response, side effects, other conditions and goals.

Online posts quoting an "average" usually describe one clinic or one forum. Read them as anecdotes, not guidance. Your dose should come from your prescriber.

## Lowest maintenance dose of tirzepatide

The lowest maintenance option named on the original Zepbound label is 5 mg once weekly. The starting dose is lower, but the label describes it as a starting step, not a maintenance dose.

Anything below the lowest labelled maintenance option is off-label. That is where "microdosing" lives. It is a provider decision, made for an individual, with limited published evidence behind it.

Branded pens are fixed-dose. Their labels do not support splitting a dose or counting clicks. That is one reason sub-label doses, when prescribed, usually come from a compounding pharmacy. Our article on [why microdosing requires compounding](https://telosrx.com/blogs/glp1/why-microdosing-requires-compounding) explains more.

## Starting, step-up and maintenance doses: the terms

Dose words get mixed up online. Here is what each one usually means.

-   **Starting dose.** The first, low dose meant to help your body adjust. The label does not describe it as a long-term dose.
-   **Step-up doses.** The gradual increases a prescriber may make while watching your response and side effects.
-   **Maintenance dose.** The dose you stay on long term, chosen for response and tolerability.
-   **Microdose.** An informal, off-label term for a provider-prescribed dose below the labelled schedule.

Knowing these terms makes conversations with your provider easier. It also helps you spot posts that blur them together.

## Branded and compounded maintenance compared

| Feature | Zepbound or Mounjaro | Compounded tirzepatide |
| --- | --- | --- |
| FDA status | Zepbound and Mounjaro are FDA-approved | Not FDA-approved |
| Maintenance options | Fixed options listed on the label | Set individually by the prescriber |
| Format | Fixed-dose pens or vials | Varies by pharmacy |
| Sub-label dosing | Not supported by the label | Off-label, provider decision |
| Evidence base | Large published trials | Limited for sub-label doses |

This table compares features, not results. It is not a guide to choosing a dose.

## What the maintenance research found

Two trials speak most directly to maintenance. One has results. One is still running.

### SURMOUNT-4: continuing versus stopping

[SURMOUNT-4, published in JAMA in 2024](https://pubmed.ncbi.nlm.nih.gov/38078870/), gave adults with obesity open-label tirzepatide at their maximum tolerated dose for 36 weeks. Then they were randomised to keep going or switch to placebo for 52 weeks.

People switched to placebo regained much of the weight they had lost. People who kept taking tirzepatide largely held their weight. The study tested continuing the higher dose, not stepping down.

The main lesson: stopping tirzepatide was linked with regain in this trial. It did not test lower maintenance doses at all.

### SURMOUNT-MAINTAIN: testing a lower dose

A newer trial, [SURMOUNT-MAINTAIN](https://pubmed.ncbi.nlm.nih.gov/40916045/), is designed to answer the step-down question. After a weight-loss phase, participants are randomised to 5 mg, their maximum tolerated dose, or placebo.

The design paper was published in 2025, and results were not reported in it. Until results appear, nobody can say how a lower labelled dose compares for maintenance.

Considering a lower dose for the long term?

telos rx offers compounded microdosed tirzepatide for weight management, subject to medical approval by a licensed provider. Your provider sets and adjusts the dose asynchronously.

[Explore microdosed tirzepatide](https://telosrx.com/pages/microdosed-tirzepatide)

## Why the label lists more than one maintenance dose

People respond differently to tirzepatide. Some feel strong appetite effects at a lower dose. Others feel little until a higher one.

Side effects vary too. A dose that suits one person may cause ongoing nausea in another. Offering several maintenance options lets prescribers match the dose to the person.

That is also why there is no universal "best" maintenance dose. The right one is the dose that works acceptably for you, as judged with your prescriber.

## Maintenance when you have other health conditions

Other conditions can shape maintenance decisions. Type 2 diabetes, kidney problems, gallbladder history and digestive disorders all matter.

Some medicines also interact. Tirzepatide slows stomach emptying, which can affect oral medicines, including oral contraceptives, as the label notes. Your provider needs your full list.

If another clinician manages a long-term condition, keep them informed. Joined-up care makes maintenance safer.

## Tirzepatide maintenance dose after goal weight

Reaching a goal weight is a good moment for a check-in with your prescriber. It is not a moment to change your dose on your own.

Prescribers typically look at a few things before deciding what comes next:

-   How stable your weight has been over recent weeks
-   Your appetite, hunger cues and eating patterns
-   Side effects at your current dose
-   Other health conditions and medications
-   Recent labs, if your provider orders them
-   Your own preferences and long-term goals

Options a prescriber may discuss include staying on the current dose, moving to a lower labelled dose, or, off-label, a lower individualised dose. Each choice has trade-offs. The research above shows stopping was linked with regain.

Our guide to [GLP-1 long-term maintenance](https://telosrx.com/blogs/glp1/glp1-long-term-maintenance) covers the bigger picture, including habits that support it.

## Microdosing tirzepatide for maintenance

"Microdosing" is not an FDA-recognised dosing category. It means a provider-prescribed dose below the standard labelled titration schedule. It is off-label.

Some people and providers are interested in microdosed tirzepatide as a lower long-term option. The idea is fewer side effects while keeping some appetite support. The published evidence for sub-label doses is limited, so that idea is still untested in trials.

Compounded tirzepatide is not FDA-approved. If a provider prescribes a microdose, they choose the amount and adjust it over time. You should never improvise your own lower dose from a branded pen.

For a side-by-side look at the two strategies, read [microdosing vs tapering GLP-1](https://telosrx.com/blogs/glp1/microdosing-vs-tapering-glp-1). For how a microdose compares with standard dosing, see [microdose vs standard tirzepatide](https://telosrx.com/blogs/glp1/microdose-vs-standard-tirzepatide).

## Why online dose charts are unreliable

You will find charts online that promise a "maintenance schedule". Be careful with them.

-   **Concentrations differ.** Compounded vials vary by pharmacy, so the same number can mean different amounts.
-   **Pens are fixed-dose.** Branded pen labels do not support splitting or click counting.
-   **Charts ignore you.** They cannot account for your health, side effects or other medicines.
-   **Sources are unclear.** Many charts cite no study at all.

With telos rx, the medication ships ready to inject. You do not mix, convert or calculate anything. Your provider decides the dose.

## Side effects at maintenance doses

Side effects often ease once a dose is stable, but not for everyone. Common ones on the label are digestive, such as nausea, diarrhoea, constipation and vomiting.

The label also lists serious warnings. These include a boxed warning about thyroid C-cell tumours in rodents, plus pancreatitis and gallbladder problems. Tell your provider about any severe or ongoing symptoms.

Dose changes, up or down, can shift side effects. Our article on [tirzepatide dose escalation side effects](https://telosrx.com/blogs/glp1/tirzepatide-dose-escalation-side-effects) explains why.

## Habits that support maintenance

Medication is one part of maintenance. Habits do a lot of the work too.

-   Prioritise protein at meals to help protect muscle
-   Do some resistance training each week
-   Keep regular sleep hours
-   Track your weight in a way that feels calm, not obsessive
-   Keep in touch with your provider if things change

These habits matter whichever dose your prescriber chooses. They also matter if you ever stop medication.

## When to message your provider

At maintenance, small changes are worth reporting. Message your provider if you notice any of these:

-   Steady weight regain over several weeks
-   Hunger or food noise returning strongly
-   New or worsening digestive symptoms
-   Severe stomach pain, which needs urgent care
-   A new diagnosis or a new medication
-   Plans for pregnancy, which change the plan entirely

Your provider may adjust the dose, order labs or suggest a different approach. Asynchronous messaging means you can raise it when it happens, not weeks later.

## Questions to ask your prescriber

-   Which maintenance options make sense for my health history?
-   How will we judge whether my current dose is right?
-   Is a lower dose, or a microdose, reasonable for me, and why?
-   What would we do if I start to regain weight?
-   How often should I check in, and which labs do I need?

Good answers will be specific to you. Be wary of anyone who gives everyone the same maintenance plan.

## What maintenance does not mean

Maintenance is not a finish line where effort stops. It is a phase with its own goals: steady weight, comfortable side effects and good overall health.

It also does not mean you are locked into one dose. Prescribers review and adjust over time as your body and life change.

And it does not mean the end of support. Life events like travel, illness, stress or a new job can shift appetite and routine. Those are good times to check in. A plan that bends with your life is easier to keep than a rigid one. Small adjustments made early tend to be easier than big ones made late.

## How telos rx handles maintenance

telos rx is an online-first, asynchronous telehealth service. You share updates through secure messaging. A licensed provider reviews them and adjusts your plan when appropriate.

If microdosed tirzepatide is prescribed, your monthly price stays flat as your dose changes, according to the product page. It is listed as low as $116 per month, as of publication. See the [microdosed tirzepatide page](https://telosrx.com/pages/microdosed-tirzepatide) for current details.

No outcome is promised. Individual results vary, and your provider may decide a different approach suits you better.

Talk to a provider about your long-term plan

Complete a private online intake. A licensed provider reviews it asynchronously, and any prescription is subject to medical approval by a licensed provider.

[Learn about microdosed tirzepatide](https://telosrx.com/pages/microdosed-tirzepatide)

## Frequently Asked Questions

### What is the average tirzepatide maintenance dose?

There is no single published average for everyday practice. The original Zepbound label lists 5 mg, 10 mg and 15 mg once weekly as recommended maintenance dosages. Prescribers choose based on response and tolerability. Online averages usually reflect one clinic or forum. Your prescriber decides what fits you.

### What is the lowest maintenance dose of tirzepatide?

The lowest maintenance option on the original Zepbound label is 5 mg once weekly. The starting dose is lower but is described as a starting step. Anything below the lowest labelled maintenance option is off-label, often called microdosing, and must be prescribed and adjusted by a licensed provider.

### What happens to the tirzepatide maintenance dose after goal weight?

Your prescriber reviews your weight stability, appetite, side effects and health, then discusses options. These may include staying on your dose, a lower labelled dose, or an off-label lower dose. In SURMOUNT-4, people who stopped tirzepatide regained much of their lost weight. Do not change your dose yourself.

### Is microdosing tirzepatide for maintenance effective?

The evidence is limited. Microdosing is not an FDA-recognised dosing category, and no completed trial has tested sub-label tirzepatide for maintenance. SURMOUNT-MAINTAIN is testing a lower labelled dose. Compounded tirzepatide is not FDA-approved. A licensed provider can tell you whether a microdose is reasonable for you.

### Can I split my Zepbound pen to get a lower maintenance dose?

No. Zepbound and Mounjaro pens are fixed-dose, and their labels do not support splitting doses or counting clicks. If a lower dose is appropriate, your prescriber decides how to provide it. With telos rx, microdosed tirzepatide ships ready to inject, so you never mix or measure.

### Do I have to stay on tirzepatide forever?

Not necessarily, but stopping is linked with regain in research. SURMOUNT-4 found people switched to placebo regained much of their lost weight. Some people discuss a lower dose, a taper or stopping with their provider. The right path depends on your health and goals, and individual results vary.

_telos rx is LegitScript-certified. Compounded medications are not FDA-approved and are prepared under federal compounding regulations. Approval is subject to evaluation by a licensed provider; approval is not guaranteed. Individual results vary. telos rx operates as an online-first, asynchronous telehealth service._

Ready to see if it fits? [Start your private evaluation with telos rx](https://telosrx.com/pages/microdosed-tirzepatide).

**Tags:** cc-107, content-calendar, GLP-1 maintenance, maintenance dose, microdosed tirzepatide, microdosing-cluster, tirzepatide, weight maintenance

---

> Source: [Telos RX](https://www.telosrx.com/blogs/glp1/tirzepatide-maintenance-dose)
